Company Monitoring Page for Roche

latest headlines for company on cafepharma

Did Novartis try to sabotage Avastin ophthalmic trials?
BioPharma Dive
Mon, 04/6/15 - 10:54 am
Tags:
Novartis, Avastin, Roche, Lucentis
BMJ: Novartis tried to 'scupper' trials to protect Lucentis from cheap Avastin
Fierce Pharma
Thu, 04/2/15 - 11:52 am
Tags:
Novartis, clinical trials, Roche, Avastin, Lucentis
Roche open to alliances in hunt for cancer drug combinations
Yahoo/Reuters
Wed, 04/1/15 - 08:39 am
Tags:
Roche, immuno-oncology
Genentech project to add 100 jobs
Fierce Pharma
Fri, 03/27/15 - 10:24 am
Tags:
Genentech, Roche, drug manufacturing
Prothena rockets up with early data on a Roche-partnered Parkinson's drug
Fierce Biotech
Fri, 03/20/15 - 08:24 am
Tags:
Roche, Prothena, PRX002, Parkinson's Disease
Top 15 pharma companies by 2014 revenue
Fierce Pharma
Wed, 03/18/15 - 11:04 am
Tags:
JNJ, Novartis, Roche, Pfizer, Sanofi, Merck, GSK, AstraZeneca, Bayer
Amgen, Inc. Plans For Biosimilar Launches
Bidness Etc.
Tue, 03/10/15 - 08:21 am
Tags:
Amgen, biosimilars, Roche, AbbVie, Neupogen
Expect More M&A Activity In Red-Hot Biotech Group
Investors.com
Fri, 03/6/15 - 03:09 pm
Tags:
biotech, M&A, AbbVie, Pharmacyclics, Isis Pharmaceuticals, JNJ, Merck, NewLink Genetics, Roche
UK doctors lobby for off-label Avastin use
Medical Marketing and Media
Tue, 02/24/15 - 06:59 pm
Tags:
UK, Avastin, off-label, Lucentis, wet age-related macular degeneration, Roche, Novartis
Residents want to sue Roche before it gives up New Jersey campus
Fierce Pharma
Thu, 02/19/15 - 01:53 pm
Tags:
Roche, New Jersey
Roche and Exelixis roll toward FDA approval with a melanoma cocktail
Fierce Biotech
Thu, 02/19/15 - 10:41 am
Tags:
Roche, Exelixis, FDA, melanoma, Cobimetinib, Zelboraf, BRAF inhibitor
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
Tags:
M&A, Actavis, Allergan, Forest Labs, GSK, Novartis, Bayer, Merck, Cubist Pharma, Roche, InterMune, Mylan Labs, Abbott Labs, Questcor, Mallinckrodt, Eli Lilly, Sun Pharma, Ranbaxy
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool
Wed, 02/18/15 - 10:56 am
Tags:
Pfizer, immuno-oncology, AstraZeneca, Bristol-Myers Squibb, Merck, Roche
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Tags:
Humira, Sovaldi, Remicade, Enbrel, Lantus, Rituxan, Advair, Avastin, Herceptin, Januvia, Merck, AbbVie, Gilead Sciences, JNJ, Amgen, Pfizer, Sanofi, Roche, GSK
Supplies of Roche's Tamiflu drained in HK as monthlong H3N2 outbreak hits
Fierce Pharma
Thu, 02/12/15 - 10:08 am
Tags:
Roche, Tamiflu, influenza, Hong Kong, H3N2
Pharma Files Complaint Against Italy for Reimbursing Off-Label Prescribing
WSJ Pharmalot
Tue, 02/10/15 - 06:40 pm
Tags:
Italy, off-label, Avastin, Lucentis, Roche, Novartis
Roche's blockbuster Lucentis nabs fourth FDA approval
BioPharma Dive
Mon, 02/9/15 - 06:01 pm
Tags:
Roche, Lucentis, FDA, DME, diabetic macular edema
Parkinson’s Study Dims Ambitions for Gene Flaw
Bloomberg
Thu, 02/5/15 - 05:09 pm
Tags:
Parkinson's Disease, Roche, LRRK2
Roche's Tamiflu vindicated in new analysis of data
BioPharma Dive
Mon, 02/2/15 - 11:11 am
Tags:
Roche, Tamiflu, influenza
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Tags:
Ophthotech, Novartis, Regeneron, Fovista, Roche, Avastin, Eylea, Lucentis, wet age-related macular degeneration

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.